ID

42754

Description

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02002702

Lien

https://clinicaltrials.gov/show/NCT02002702

Mots-clés

Versions (2)
  1. 04/12/2015 04/12/2015 -
  2. 17/09/2021 17/09/2021 -
Téléchargé le

17 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Heart Failure NCT02002702

Anglais

Eligibility Acute Heart Failure NCT02002702

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent must be obtained before any study-specific assessment is performed.
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
male or female ≥20 years of age
Description

Patient age and sex

Type de données

boolean

Alias
UMLS CUI [1]
C0150831
UMLS CUI [2]
C0001779
hospitalized for ahf; ahf is defined as including all of the followings measured at any time between presentation (including the emergency department) and the end of screening:
Description

hospitalized for ahf

Type de données

boolean

Alias
UMLS CUI [1]
C0264714
UMLS CUI [2]
C0870668
dyspnea at rest or with minimal exertion
Description

dyspnea

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013404
UMLS CUI [1,2]
C0231807
pulmonary congestion on chest x-ray,
Description

pulmonary congestion

Type de données

boolean

Alias
UMLS CUI [1]
C0242073
bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml
Description

bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml

Type de données

boolean

Alias
UMLS CUI [1]
C1095989
UMLS CUI [2]
C3272900
sbp ≥125 mmhg at the start and at the end of screening
Description

sbp ≥125 mmhg at the start and at the end of screening

Type de données

boolean

Alias
UMLS CUI [1]
C0871470
able to be randomized within 16 hours from presentation to the hospital, including the emergency department
Description

randomized within 16 hours from presentation to the hospital

Type de données

boolean

Alias
UMLS CUI [1]
C1320532
received intravenous (iv) furosemide of at least 40 mg (or equivalent) at any time between presentation (this include outpatient clinic, ambulance, or hospital including emergency department) and the start of screening for the study for the treatment of the current acute heart failure (hf) episode.
Description

received intravenous (iv) furosemide

Type de données

boolean

Alias
UMLS CUI [1,1]
C0354100
UMLS CUI [1,2]
C1391960
impaired renal function defined as an estimated glomerular filtration rate (egfr) between presentation and randomization of ≥ 25 and≤ 75 ml/min/1.73 m2, calculated using the japanese formula
Description

impaired renal function

Type de données

boolean

Alias
UMLS CUI [1]
C1565489
with body weight ≥30 kg and ≤160 kg
Description

body weight

Type de données

text

Alias
UMLS CUI [1]
C0005910
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
dyspnea primarily due to non-cardiac causes
Description

dyspnea non cardiac

Type de données

boolean

Alias
UMLS CUI [1]
C0013404
temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment
Description

temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0015967
clinical evidence of acute coronary syndrome currently or within 30 days prior to enrollment.
Description

acute coronary syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0948089
ahf due to significant arrhythmias, which include any of the following: sustained ventricular tachycardia, bradycardia with sustained ventricular rate <45 beats per minute, or atrial fibrillation/flutter with sustained ventricular response of >130 beats per minute.
Description

significant arrhythmias

Type de données

boolean

Alias
UMLS CUI [1]
C0003811
other protocol defined inclusion/exclusion criteria may apply.
Description

other protocol defined inclusion/exclusion criteria may apply

Type de données

boolean

Alias
UMLS CUI [1]
C0205394
UMLS CUI [2]
C1516637
Retour au début de la page

Similar models

Eligibility Acute Heart Failure NCT02002702

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent
Item
written informed consent must be obtained before any study-specific assessment is performed.
boolean
C0021430 (UMLS CUI [1])
Patient age and sex
Item
male or female ≥20 years of age
boolean
C0150831 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
hospitalized for ahf
Item
hospitalized for ahf; ahf is defined as including all of the followings measured at any time between presentation (including the emergency department) and the end of screening:
boolean
C0264714 (UMLS CUI [1])
C0870668 (UMLS CUI [2])
dyspnea
Item
dyspnea at rest or with minimal exertion
boolean
C0013404 (UMLS CUI [1,1])
C0231807 (UMLS CUI [1,2])
pulmonary congestion
Item
pulmonary congestion on chest x-ray,
boolean
C0242073 (UMLS CUI [1])
bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml
Item
bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml
boolean
C1095989 (UMLS CUI [1])
C3272900 (UMLS CUI [2])
sbp ≥125 mmhg at the start and at the end of screening
Item
sbp ≥125 mmhg at the start and at the end of screening
boolean
C0871470 (UMLS CUI [1])
randomized within 16 hours from presentation to the hospital
Item
able to be randomized within 16 hours from presentation to the hospital, including the emergency department
boolean
C1320532 (UMLS CUI [1])
received intravenous (iv) furosemide
Item
received intravenous (iv) furosemide of at least 40 mg (or equivalent) at any time between presentation (this include outpatient clinic, ambulance, or hospital including emergency department) and the start of screening for the study for the treatment of the current acute heart failure (hf) episode.
boolean
C0354100 (UMLS CUI [1,1])
C1391960 (UMLS CUI [1,2])
impaired renal function
Item
impaired renal function defined as an estimated glomerular filtration rate (egfr) between presentation and randomization of ≥ 25 and≤ 75 ml/min/1.73 m2, calculated using the japanese formula
boolean
C1565489 (UMLS CUI [1])
body weight
Item
with body weight ≥30 kg and ≤160 kg
text
C0005910 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
dyspnea non cardiac
Item
dyspnea primarily due to non-cardiac causes
boolean
C0013404 (UMLS CUI [1])
temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment
Item
temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment
boolean
C0015967 (UMLS CUI [1])
acute coronary syndrome
Item
clinical evidence of acute coronary syndrome currently or within 30 days prior to enrollment.
boolean
C0948089 (UMLS CUI [1])
significant arrhythmias
Item
ahf due to significant arrhythmias, which include any of the following: sustained ventricular tachycardia, bradycardia with sustained ventricular rate <45 beats per minute, or atrial fibrillation/flutter with sustained ventricular response of >130 beats per minute.
boolean
C0003811 (UMLS CUI [1])
other protocol defined inclusion/exclusion criteria may apply
Item
other protocol defined inclusion/exclusion criteria may apply.
boolean
C0205394 (UMLS CUI [1])
C1516637 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial